Owner Viventia Biotech Inc.

Inventors Chahal, Francina C.; Cizeau, Jeannick

Agent Davies Collison Cave

Pub. Number AU-A-2008316224

PCT Pub. Number WO2009/052628

Priority 60/982,575 25.10.07 US

Filing date 23 October 2008

Wipo publication date 30 April 2009

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 14/21 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances